FDA Warning Letter — BP

Case 640116 — FEI 3015159836

The FDA took a Warning Letter action against BP on Aug 18, 2022 (Philadelphia, PA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Aug 18, 2022
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Philadelphia, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.